© 2015, Springer-Verlag Berlin Heidelberg. Purpose: The efficacy of most anticancer treatments, including radiotherapy, depends on an ability to cause DNA double-strand breaks (DSBs). Very early during the DNA damage signalling process, the histone isoform H2AX is phosphorylated to form γH2AX. With the aim of positron emission tomography (PET) imaging of DSBs, we synthesized a 89Zr-labelled anti-γH2AX antibody, modified with the cell-penetrating peptide, TAT, which includes a nuclear localization sequence. Methods: 89Zr-anti-γH2AX-TAT was synthesized using EDC/NHS chemistry for TAT peptide linkage. Desferrioxamine conjugation allowed labelling with 89Zr. Uptake and retention of 89Zr-anti-γH2AX-TAT was evaluated in the breast adenocarcinoma ...
PURPOSE: The chimeric monoclonal antibody (mAb) chDAB4 (APOMAB®) targets the Lupus associated (La)/S...
Purpose: Late-stage, unresectable pancreatic ductal adenocarcinoma (PDAC) is largely resistant to ch...
PURPOSE: The aims of the study were to develop and evaluate a novel residualizing peptide for labeli...
PURPOSE: The efficacy of most anticancer treatments, including radiotherapy, depends on an ability t...
DNA damage responses (DDR) occur during oncogenesis and therapeutic responses to DNA damaging cytoto...
Rationale: The evaluation of early treatment response is critical for patient prognosis and treatmen...
UNLABELLED: A prominent feature of many human cancers is oncogene-driven activation of the DNA damag...
Introduction: DNA damage repair (DDR) signalling is upregulated during tumorigenesis and acts as a p...
A prominent feature of many human cancers is oncogene-driven activation of the DNA damage response (...
A prominent feature of many human cancers is oncogene-driven activation of the DNA damage response (...
(111)In-DTPA-anti-γH2AX-Tat, which combines an anti-γH2AX antibody with a cell-penetrating peptide, ...
Objectives: To facilitate dosimetric calculations in -emitter therapy, new concepts, preferably base...
111In-DTPA-anti-γH2AX-Tat, which combines an anti-γH2AX antibody with a cell-penetrating peptide, Ta...
Many anticancer therapies, including radiotherapy, act by damaging the deoxyribosenucleic acid (DNA)...
DNA double-strand breaks (DSBs) are formed as a result of genotoxic insults, such as exogenous ioni...
PURPOSE: The chimeric monoclonal antibody (mAb) chDAB4 (APOMAB®) targets the Lupus associated (La)/S...
Purpose: Late-stage, unresectable pancreatic ductal adenocarcinoma (PDAC) is largely resistant to ch...
PURPOSE: The aims of the study were to develop and evaluate a novel residualizing peptide for labeli...
PURPOSE: The efficacy of most anticancer treatments, including radiotherapy, depends on an ability t...
DNA damage responses (DDR) occur during oncogenesis and therapeutic responses to DNA damaging cytoto...
Rationale: The evaluation of early treatment response is critical for patient prognosis and treatmen...
UNLABELLED: A prominent feature of many human cancers is oncogene-driven activation of the DNA damag...
Introduction: DNA damage repair (DDR) signalling is upregulated during tumorigenesis and acts as a p...
A prominent feature of many human cancers is oncogene-driven activation of the DNA damage response (...
A prominent feature of many human cancers is oncogene-driven activation of the DNA damage response (...
(111)In-DTPA-anti-γH2AX-Tat, which combines an anti-γH2AX antibody with a cell-penetrating peptide, ...
Objectives: To facilitate dosimetric calculations in -emitter therapy, new concepts, preferably base...
111In-DTPA-anti-γH2AX-Tat, which combines an anti-γH2AX antibody with a cell-penetrating peptide, Ta...
Many anticancer therapies, including radiotherapy, act by damaging the deoxyribosenucleic acid (DNA)...
DNA double-strand breaks (DSBs) are formed as a result of genotoxic insults, such as exogenous ioni...
PURPOSE: The chimeric monoclonal antibody (mAb) chDAB4 (APOMAB®) targets the Lupus associated (La)/S...
Purpose: Late-stage, unresectable pancreatic ductal adenocarcinoma (PDAC) is largely resistant to ch...
PURPOSE: The aims of the study were to develop and evaluate a novel residualizing peptide for labeli...